title: Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.
abstract: Mercury (Hg) is neurotoxic, and children may be particularly susceptible to this effect. A current major challenge is identification of children who may be uniquely susceptible to Hg toxicity because of genetic predisposition. We examined the possibility that common genetic variants that are known to affect neurologic functions or Hg handling in adults would modify the adverse neurobehavioral effects of Hg exposure in children. Three hundred thirty subjects who participated as children in the recently completed Casa Pia Clinical Trial of Dental Amalgams in Children were genotyped for 27 variants of 13 genes that are reported to affect neurologic functions and/or Hg disposition in adults. Urinary Hg concentrations, reflecting Hg exposure from any source, served as the Hg exposure index. Regression modeling strategies were employed to evaluate potential associations between allelic status for individual genes or combinations of genes, Hg exposure, and neurobehavioral test outcomes assessed at baseline and for 7 subsequent years during the clinical trial. Among boys, significant modification of Hg effects on neurobehavioral outcomes over a broad range of neurologic domains was observed with variant genotypes for 4 of 13 genes evaluated. Modification of Hg effects on a more limited number of neurobehavioral outcomes was also observed for variants of another 8 genes. Cluster analyses suggested some genes interacting in common processes to affect Hg neurotoxicity. In contrast, significant modification of Hg effects on neurobehavioral functions among girls with the same genotypes was substantially more limited. These observations suggest increased susceptibility to the adverse neurobehavioral effects of Hg among children, particularly boys, with genetic variants that are relatively common to the general human population. These findings advance public health goals to identify factors underlying susceptibility to Hg toxicity and may contribute to strategies for preventing adverse health risks associated with Hg exposure.
authors.affiliation: Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA. Electronic address: jwoods@uw.edu.
authors.forename: James S
authors.initials: JS
authors.lastname: Woods
authors.affiliation: Battelle Centers for Public Health Research and Evaluation, Seattle, WA, USA.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Heyer
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
authors.forename: Joan E
authors.initials: JE
authors.lastname: Russo
authors.affiliation: Departments of Oral Medicine and Epidemiology, University of Washington, Seattle, WA, USA.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Martin
authors.affiliation: Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
authors.forename: Federico M
authors.initials: FM
authors.lastname: Farin
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic; D004198:Disease Susceptibility / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D020262:Mercury Poisoning, Nervous System / Q000235:genetics* / Q000523:psychology*; D009483:Neuropsychological Tests; D011110:Polymorphism, Genetic
keywords: Children; Genetic susceptibility; Mercury; Neurobehavioral function; Neurotoxicity
references.citation: Metallomics. 2014 Mar;6(3):662-71
references.pmid: 24549367
references.citation: Mol Psychiatry. 1996 Dec;1(6):453-60
references.pmid: 9154246
references.citation: J Neurosci. 2009 Oct 14;29(41):12815-23
references.pmid: 19828794
references.citation: Science. 2003 Jul 18;301(5631):386-9
references.pmid: 12869766
references.citation: Mol Pharmacol. 1999 Jul;56(1):31-8
references.pmid: 10385681
references.citation: Int J Neurosci. 2008 Jan;118(1):79-93
references.pmid: 18041607
references.citation: Environ Health Perspect. 2007 Oct;115(10):1527-31
references.pmid: 17938746
references.citation: Toxicol Appl Pharmacol. 2011 Dec 1;257(2):301-8
references.pmid: 21967774
references.citation: Arch Biochem Biophys. 2000 May 1;377(1):195-203
references.pmid: 10775460
references.citation: Neuropsychopharmacology. 2008 Dec;33(13):3037-45
references.pmid: 17805313
references.citation: Exp Biol Med (Maywood). 2006 Oct;231(9):1468-73
references.pmid: 17018868
references.citation: J Toxicol Environ Health A. 2008;71(19):1318-26
references.pmid: 18686203
references.citation: Int J Neurosci. 2005 Dec;115(12):1687-709
references.pmid: 16287634
references.citation: Science. 1996 Nov 29;274(5292):1527-31
references.pmid: 8929413
references.citation: Neurotoxicol Teratol. 2013 Sep-Oct;39:36-44
references.pmid: 23827881
references.citation: Science. 2006 Oct 20;314(5798):475-8
references.pmid: 17053149
references.citation: Neurotoxicol Teratol. 2012 Sep-Oct;34(5):513-21
references.pmid: 22765978
references.citation: Environ Health Perspect. 2008 Jun;116(6):734-9
references.pmid: 18560528
references.citation: Metallomics. 2011 Oct;3(10):955-62
references.pmid: 21922110
references.citation: Environ Mol Mutagen. 2013 Apr;54(3):195-203
references.pmid: 23444121
references.citation: Neurotoxicol Teratol. 1997 Nov-Dec;19(6):417-28
references.pmid: 9392777
references.citation: Pediatr Res. 2003 Dec;54(6):819-25
references.pmid: 12930912
references.citation: Annu Rev Pharmacol Toxicol. 1999;39:19-52
references.pmid: 10331075
references.citation: Science. 2002 Jun 21;296(5576):2225-9
references.pmid: 12029063
references.citation: J Toxicol Environ Health A. 2014;77(6):293-312
references.pmid: 24593143
references.citation: Environ Res. 2009 Aug;109(6):786-96
references.pmid: 19515364
references.citation: Neurotoxicology. 2008 May;29(3):489-503
references.pmid: 18313142
references.citation: J Neurosci. 2003 Sep 10;23(23):8212-20
references.pmid: 12967982
references.citation: Toxicol Appl Pharmacol. 2005 Aug 7;206(2):113-20
references.pmid: 15967199
references.citation: Am J Psychiatry. 2003 Apr;160(4):671-6
references.pmid: 12668354
references.citation: Environ Sci Technol. 2013 Apr 2;47(7):3403-9
references.pmid: 23463943
references.citation: Environ Toxicol Chem. 2014 Jun;33(6):1248-58
references.pmid: 24038486
references.citation: Nat Genet. 2010 Nov;42(11):1021-6
references.pmid: 20890276
references.citation: J Toxicol Environ Health A. 2010;73(15):1003-20
references.pmid: 20526950
references.citation: Neurotoxicol Teratol. 1995 Mar-Apr;17(2):161-8
references.pmid: 7760775
references.citation: Toxicol Sci. 2009 Jun;109(2):228-36
references.pmid: 19339664
references.citation: J Neurosci. 1999 Jun 15;19(12):4867-80
references.pmid: 10366621
references.citation: Pharmacogenetics. 1996 Aug;6(4):307-18
references.pmid: 8873217
references.citation: Nat Rev Genet. 2007 Apr;8(4):253-62
references.pmid: 17363974
references.citation: Health Aff (Millwood). 2011 May;30(5):842-50
references.pmid: 21543423
references.citation: J Autoimmun. 2001 Aug;17(1):27-37
references.pmid: 11488635
references.citation: Curr Opin Pediatr. 2009 Apr;21(2):243-51
references.pmid: 19663042
references.citation: Regul Toxicol Pharmacol. 2008 Jul;51(2):215-29
references.pmid: 18482784
references.citation: Am J Psychiatry. 2009 Aug;166(8):909-16
references.pmid: 19605537
references.citation: Genetica. 2009 Jun;136(2):259-69
references.pmid: 19363597
references.citation: Toxicol Sci. 2001 Jun;61(2):224-33
references.pmid: 11353131
references.citation: Science. 1983 Dec 2;222(4627):1031-3
references.pmid: 6648517
references.citation: JAMA. 2006 Apr 19;295(15):1784-92
references.pmid: 16622140
references.citation: Control Clin Trials. 2002 Jun;23(3):301-20
references.pmid: 12057882
references.citation: Cancer Res. 2008 Nov 15;68(22):9116-21
references.pmid: 19010880
references.citation: JAMA. 2006 Apr 19;295(15):1775-83
references.pmid: 16622139
references.citation: Neurotoxicol Teratol. 2006 Jan-Feb;28(1):39-48
references.pmid: 16343843
references.citation: Neurotoxicology. 1995 Winter;16(4):653-64
references.pmid: 8714870
references.citation: Neurotoxicol Teratol. 2005 Nov-Dec;27(6):781-96
references.pmid: 16301096
references.citation: Science. 2012 Dec 7;338(6112):1357-60
references.pmid: 23224557
references.citation: Sci Total Environ. 2007 Oct 15;385(1-3):37-47
references.pmid: 17716707
references.citation: PLoS One. 2009;4(4):e5237
references.pmid: 19365560
references.citation: J Nutr. 2007 Mar;137(3):690-3
references.pmid: 17311961
references.citation: Neurobiol Aging. 2008 Jul;29(7):1123-5
references.pmid: 17353070
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):63-8
references.pmid: 14755447
references.citation: Environ Health Perspect. 2002 Oct;110 Suppl 5:855-8
references.pmid: 12426146
references.citation: Neurotoxicol Teratol. 2001 Nov-Dec;23(6):569-89
references.pmid: 11792526
references.citation: Environ Health Perspect. 2012 Apr;120(4):530-4
references.pmid: 22233731
references.citation: Toxicol Sci. 2004 Oct;81(2):354-63
references.pmid: 15254338
references.citation: Mol Brain. 2009 Mar 27;2:8
references.pmid: 19323847
references.citation: Mol Psychiatry. 2004 May;9(5):494-9
references.pmid: 14699423
references.citation: Cell. 2003 Jan 24;112(2):257-69
references.pmid: 12553913
references.citation: Toxicol Sci. 2010 Oct;117(2):263-9
references.pmid: 20631062
references.citation: Mol Pharmacol. 2006 Mar;69(3):697-705
references.pmid: 16306232
references.citation: Neurotoxicol Teratol. 2008 Mar-Apr;30(2):88-95
references.pmid: 18226494
references.citation: Neurotoxicology. 2013 Jul;37:85-92
references.pmid: 23603214
references.citation: Environ Health Perspect. 2002 Feb;110 Suppl 1:11-23
references.pmid: 11834460
references.citation: J Toxicol Environ Health A. 2009;72(9):599-609
references.pmid: 19296409
references.citation: Neurosci Lett. 1995 Jan 30;184(3):208-11
references.pmid: 7715848